Mandy Beyer

743 total citations
19 papers, 557 citations indexed

About

Mandy Beyer is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mandy Beyer has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Mandy Beyer's work include Histone Deacetylase Inhibitors Research (10 papers), Acute Myeloid Leukemia Research (5 papers) and Protein Degradation and Inhibitors (5 papers). Mandy Beyer is often cited by papers focused on Histone Deacetylase Inhibitors Research (10 papers), Acute Myeloid Leukemia Research (5 papers) and Protein Degradation and Inhibitors (5 papers). Mandy Beyer collaborates with scholars based in Germany, United Kingdom and Egypt. Mandy Beyer's co-authors include Oliver H. Krämer, Siavosh Mahboobi, Andreas Sellmer, Manja Wobus, Martin Bornhäuser, Udo Krause‐Buchholz, Gerhard Rödel, Günter Schneider, Sigurd Elz and Stefan Dove and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mandy Beyer

19 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandy Beyer Germany 13 360 120 65 63 55 19 557
Huihong You United States 10 274 0.8× 70 0.6× 56 0.9× 56 0.9× 47 0.9× 13 522
Costakis Frangou United States 7 165 0.5× 74 0.6× 65 1.0× 45 0.7× 56 1.0× 7 443
Linda Hogarth United Kingdom 14 387 1.1× 152 1.3× 33 0.5× 82 1.3× 91 1.7× 29 666
Chris Tse United States 13 386 1.1× 121 1.0× 33 0.5× 36 0.6× 35 0.6× 26 630
Xudong Wei China 12 211 0.6× 117 1.0× 42 0.6× 84 1.3× 109 2.0× 68 434
Sita Kugel Desmoulin United States 12 450 1.3× 91 0.8× 25 0.4× 40 0.6× 74 1.3× 12 692
Paolo Pagani Italy 7 652 1.8× 177 1.5× 185 2.8× 89 1.4× 128 2.3× 17 851
Rosario Garrido United States 9 335 0.9× 235 2.0× 40 0.6× 71 1.1× 62 1.1× 11 651
Christina Economopoulou Greece 8 221 0.6× 73 0.6× 39 0.6× 58 0.9× 96 1.7× 15 401
Sharon Wu United States 13 274 0.8× 247 2.1× 56 0.9× 113 1.8× 53 1.0× 68 604

Countries citing papers authored by Mandy Beyer

Since Specialization
Citations

This map shows the geographic impact of Mandy Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Beyer more than expected).

Fields of papers citing papers by Mandy Beyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Beyer. The network helps show where Mandy Beyer may publish in the future.

Co-authorship network of co-authors of Mandy Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Beyer. A scholar is included among the top collaborators of Mandy Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Beyer. Mandy Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Beyer, Mandy, Hany S. Ibrahim, Walburgis Brenner, et al.. (2023). Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3. Leukemia. 37(11). 2319–2323. 6 indexed citations
2.
Marx, Christian, Jürgen Sonnemann, Oliver D.K. Maddocks, et al.. (2022). Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress. SHILAP Revista de lepidopterología. 10(1). 10–10. 12 indexed citations
3.
Beyer, Mandy, Simon Poepsel, Florian Heyd, et al.. (2022). Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition. Oncogene. 41(40). 4560–4572. 11 indexed citations
4.
Beyer, Mandy & Oliver H. Krämer. (2022). RNA interference protocol to silence oncogenic drivers in leukemia cell lines. STAR Protocols. 3(3). 101512–101512. 3 indexed citations
5.
Beyer, Mandy, Andrea Piée‐Staffa, Andreas Sellmer, et al.. (2021). Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Archives of Toxicology. 96(1). 177–193. 19 indexed citations
6.
Beyer, Mandy, Markus Christmann, Andreas Sellmer, et al.. (2021). Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells. Cell chemical biology. 29(3). 398–411.e4. 18 indexed citations
7.
Sellmer, Andreas, Mandy Beyer, Herwig Pongratz, et al.. (2020). A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia. European Journal of Medicinal Chemistry. 193. 112232–112232. 14 indexed citations
8.
Beyer, Mandy, A Romański, Andrea Pautz, et al.. (2019). HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1. Cancers. 11(10). 1436–1436. 28 indexed citations
9.
Sellmer, Andreas, Oliver H. Krämer, Stefan Dove, et al.. (2018). Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors. European Journal of Medicinal Chemistry. 152. 329–357. 36 indexed citations
10.
Sellmer, Andreas, Mandy Beyer, Herwig Pongratz, et al.. (2018). Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors. Journal of Medicinal Chemistry. 61(8). 3454–3477. 56 indexed citations
11.
Drube, Sebastian, Florian Kraft, Jan Dudeck, et al.. (2016). MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation. The Journal of Immunology. 197(9). 3662–3668. 49 indexed citations
12.
Wirth, Matthias, Patrick Wenzel, Mandy Beyer, et al.. (2016). HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer. Oncogene. 36(13). 1804–1815. 87 indexed citations
13.
Beyer, Mandy, Nicole Kiweler, Siavosh Mahboobi, & Oliver H. Krämer. (2016). How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot. Methods in molecular biology. 1510. 355–364. 19 indexed citations
14.
Schäfer, Claudia, Mandy Beyer, Nicole Kiweler, et al.. (2016). Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells. Cellular Signalling. 29. 218–225. 42 indexed citations
15.
Drube, Sebastian, Romy Loschinski, Mandy Beyer, et al.. (2015). Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells. Oncotarget. 6(7). 5354–5368. 11 indexed citations
16.
Beyer, Mandy, et al.. (2012). OXPHOS Supercomplexes as a Hallmark of the Mitochondrial Phenotype of Adipogenic Differentiated Human MSCs. PLoS ONE. 7(4). e35160–e35160. 84 indexed citations
17.
Yassin, Mohammed A., Andrew Kirby, Isabel Arbide, et al.. (2012). Unusual norovirus and rotavirus genotypes in Ethiopia. Paediatrics and International Child Health. 32(1). 51–55. 24 indexed citations
18.
Kirby, Andrew, Najla Al‐Sonboli, Taghreed A. Hafiz, et al.. (2011). Rotavirus and norovirus infections in children in Sana’a, Yemen. Tropical Medicine & International Health. 16(6). 680–684. 26 indexed citations
19.
Burchenal, Joseph H., Martha K. Dagg, Mandy Beyer, & Christiane Stock. (1956). Chemotherapy of Leukemia VII. Effect of Substituted Triazenes on Transplanted Mouse Leukemia.. Experimental Biology and Medicine. 91(3). 398–401. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026